Program: Sunday (24.10.2010)

09:00 – 12:15

Room: Kleiner Saal

Patiententag An Interactive Survivor Symposium with Focus on Quality of Life

09:30 – 10:30

Room: Großer Saal

Scientific Session The HL Stem Cell

  • Bernd Dörken
  • Randy Gascoyne
  • Leukaemic Stem Cells: AML Show the Way

    • Dominique Bonnet
  • Cancer Stem Cells in Hodgkin Lymphoma

    • Richard Ambinder
  • Aspects of the Relationship of Hodgkin and Reed/Sternberg Cells and Potential Precursor Cells

    • Ralf Küppers

10:30 – 12:00

Room: Großer Saal

Scientific Session Lymphoma Microenvironment

  • Margaret Shipp
  • Harald Stein
  • Classical Hodgkin Lymphoma Micro- environment. Pathologic Aspects and the Role of CD40 / CD40L

    • Antonio Carbone
  • Gene and Micro-RNAs Signatures as Predictors of Risk in Hodgkin Lymphoma: Integrating Tumor and Microenvironment

    • Juan F García
  • Can Immunohistochemical Markers at Diagnosis Have the Same Predictive Value of Early Interim-PET in Classical Hodgkin Lymphoma?

    • Stefano Pileri
  • Integrative Analysis Reveals Selective 9p24.1 Ampli cation, Increased PD-L1 Ligand Expression and Further Induction via JAK2 in Nodular Sclerosing Hodgkin Lymphoma and Primary Mediastinal Large B-Cell Lymphoma

    • Margaret Shipp

12:15 – 13:30

Room: Großer Saal

Satellite Symposium Lenalidomide in Lymphoma – Latest Update on Clinical Data

  • Volker Diehl
  • Rational and Clinical Experiences with Lenalidomide in Hodgkin Lymphoma

    • Boris Böll
  • Progress in CLL Treatment

    • Clemens Wendtner
  • Emerging Treatment Options for Mantle Cell Lymphoma

    • Marek Trnĕný

14:00 – 15:00

Room: Großer Saal

Satellite Symposium CD30 as a Target for Hodgkin Lymphoma

  • Andreas Engert
  • Welcome and Introduction

    • Andreas Engert
  • Clinical Gaps in the Treatment of Patients with Relapsed/Refractory Hodgkin Lymphoma

    • Peter Johnson
  • Targeting CD30 in Hodgkin Lymphoma

    • Andreas Engert
  • Ongoing Phase III Trials in Relapsed/Refractory Hodgkin Lymphoma

    • Pauline Brice
  • Panel Discussion: Optimizing the Path to Transplant for Patients with Late-Stage Hodgkin Lymphoma

    • Pauline Brice
    • Andreas Engert
    • Peter Johnson

16:00 – 17:30

Room: Großer Saal

Satellite Symposium Novel Approaches in the Treatment of Hodgkin Lymphoma: Beyond Chemotherapy

  • Andreas Engert
  • Welcome and Introduction

    • Andreas Engert
  • DAC Inhibitors, a New Class of Compounds: Landscape and MOA

    • Anas Younes
  • Evolution of Panobinostat in Treating Hodgkin Lymphoma

    • Franck Morschhauser
  • Novartis Pipeline: Investigational Compounds in Lymphoma

    • Patrick Johnston
  • New Products (LBH)

    • Anas Younes
  • Summary and Close

    • Andreas Engert

18:00 – 20:00

Room: Großer Saal

Main Program Opening Ceremony

  • Bonadonna Lecture: The Role of Viral Infections in Hodgkin Lymphoma

    • Harald zur Hausen
  • Awards Ceremony


Room: Weinkeller

Main Program Get Together


You a viewing the program of a past symposium. Click here to get back to the current conference.